首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   48561篇
  免费   2533篇
  国内免费   236篇
耳鼻咽喉   614篇
儿科学   972篇
妇产科学   1157篇
基础医学   6208篇
口腔科学   3330篇
临床医学   3398篇
内科学   11793篇
皮肤病学   840篇
神经病学   4550篇
特种医学   1634篇
外科学   6309篇
综合类   147篇
一般理论   14篇
预防医学   3506篇
眼科学   872篇
药学   3236篇
中国医学   283篇
肿瘤学   2467篇
  2023年   344篇
  2022年   581篇
  2021年   1383篇
  2020年   799篇
  2019年   1170篇
  2018年   1701篇
  2017年   1192篇
  2016年   1289篇
  2015年   1395篇
  2014年   1791篇
  2013年   2486篇
  2012年   3985篇
  2011年   4393篇
  2010年   2280篇
  2009年   1821篇
  2008年   3439篇
  2007年   3501篇
  2006年   3142篇
  2005年   3109篇
  2004年   2858篇
  2003年   2377篇
  2002年   2040篇
  2001年   478篇
  2000年   461篇
  1999年   398篇
  1998年   311篇
  1997年   228篇
  1996年   223篇
  1995年   173篇
  1994年   167篇
  1993年   117篇
  1992年   140篇
  1991年   131篇
  1990年   99篇
  1989年   96篇
  1988年   100篇
  1987年   78篇
  1986年   82篇
  1985年   97篇
  1984年   109篇
  1983年   69篇
  1982年   82篇
  1981年   69篇
  1980年   48篇
  1979年   37篇
  1978年   47篇
  1977年   43篇
  1974年   32篇
  1973年   37篇
  1969年   33篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Henoch‐Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11‐year‐old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology.  相似文献   
5.
A growing body of data suggests that therapies based on Toll-like receptors (TLR) targeting, in particular TLR4, holds promise in curing autoimmune and inflammatory pathologies still lacking specific treatment, included several rare diseases. While TLR4 activators (agonists) have already found successful clinical application as vaccine adjuvants, the use of TLR4 blockers (antagonists) as antisepsis agents or as agents against inflammatory diseases (including arthritis, multiple sclerosis, neuroinflammations) and cancer is still at a preclinical phase of development. This minireview focuses on recent achievements on the development of TLR4 modulators based on lipid A structure simplification, in particular on compounds having disaccharide or monosaccharide structures. As the TLR4 activity of natural TLR4 ligands (lipopolysaccharide, LPS and its biologically active part, the lipid A) depends on both the structure of endotoxin aggregates in solution and on single-molecule interaction with MD-2 and CD14 receptors, the rational design of TLR4 modulators should in principle take into account both these factors. In the light of the most recent advances in the field, in this minireview we discuss the structure–activity relationship in simplified lipid A analogs, with cationic or anionic amphiphilic structures.  相似文献   
6.
7.
8.
9.
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号